D Teitelbaum1, M Sela, R Arnon. Show Affiliations » 1. Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Abstract
Entities: Chemical
Mesh： See more » Adjuvants, Immunologic/chemistryAdjuvants, Immunologic/therapeutic useAnimalsAutoimmune Diseases/drug therapyAutoimmune Diseases/immunologyClinical Trials as TopicCross ReactionsDisease Models, AnimalDrug DesignEncephalomyelitis, Autoimmune, Experimental/drug therapyEncephalomyelitis, Autoimmune, Experimental/immunologyGlatiramer AcetateHistocompatibility Antigens Class II/immunologyHumansImmunosuppressive Agents/chemistryImmunosuppressive Agents/immunologyImmunosuppressive Agents/therapeutic useIsraelLaboratoriesMultiple Sclerosis/drug therapyMultiple Sclerosis/immunologyPeptides/chemistryPeptides/immunologyPeptides/therapeutic usePolymers/chemistryPolymers/therapeutic useT-Lymphocytes/drug effectsT-Lymphocytes/immunologyT-Lymphocytes, Regulatory/drug effectsT-Lymphocytes, Regulatory/immunologyUnited StatesUnited States Food and Drug Administration
Substances： See more » Adjuvants, ImmunologicHistocompatibility Antigens Class IIImmunosuppressive AgentsPeptidesPolymersGlatiramer Acetate
Year: 1997 PMID： 9347880
Source DB: PubMed Journal: Isr J Med Sci ISSN： 0021-2180